Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran

Journal of Research in Medical Sciences

Volumn 18, Issue 12, 2013, Pages 1056-1060

  Khademi, Farzad ^a   Faghri, Jamshid ^a   Poursina, Farkhondeh ^a   Esfahani, Bahram Nasr ^a   Moghim, Sharareh ^a   Fazeli, Hossein ^a   Adibi, Peyman ^a   Mirzaei, Nasrin ^b   Akbari, Mojtaba ^a   Safaei, Hajieh Ghasemian ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Amoxicillin; Clarithromycin; Helicobacter pylori; Metronidazole

Indexed keywords

EID: 84893056898     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Duck WM, Sobel J, Pruckler JM, Song Q, Swerdlow D, Friedman C, et al. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis 2004;10:1088-94.
2. Fallahi GH, Maleknejad S. Helicobacter pylori culture and antimicrobial resistance in Iran. Indian J Pediatr 2007;4:127-30.
3. Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 2010;7:629-41.
4. Tay CY, Mitchell H, Dong Q, Goh KL, Dawes IW, Lan R. Population structure of Helicobacter pylori among ethnic groups in Malaysia: Recent acquisition of the bacterium by the Malay population. BMC Microbiol 2009;9:126.
5. Ghasemian Safaei H, Tavakkoli H, Mojtahedi A, Salehei R, Soleimani B, Pishva E. Correlation of cagA positive Helicobacter pylori Infection with clinical outcomes in Al-zahra hospital, Isfahan, Iran. J Res Med Sci 2008;13:196-201.
6. Hosseini E, Poursina F, de Wiele TV, Safaei HG, Adibi P. Helicobacter pylori in Iran: A systematic review on the association of genotypes and gastroduodenal diseases. J Res Med Sci 2012;17:280-92.
7. Kumala W, Rani A. Patterns of Helicobacter pylori isolate resistance to fluoroqinoloes, amoxicillin, clarithromycin and metronidazoles. Southeast Asian J Trop Med Public Health 2006;37:970-4.
8. Taylor DE, Ge Z, Purych D, Lo T, Hiratsuka K. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 1997;41:2621-8.
9. Haghi Tomatari F, Mohabbati Mobarez A, Amini M, Hosseini D, Talebi Bezmin Abadi A. Helicobacter pylori resistance to metronidazole and clarithromycin in dyspeptic patients in Iran. Iran Red Crescent Med J 2010;12:409-12.
10. Debets-Ossenkopp YJ, Sparrius M, Kusters JG, Kolkman JJ, Vandenbroucke-Grauls CM. Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol Lett 1996;142:37-42.
11. E-test technical guide 8: Susceptibility testing of Helicobacter pylori. Solna, Sweden: AB Biodisk; 2000.
12. De Francesco V, Giorgio F, Hassan C, Manes G, Vannella L, Panella C, et al. Worldwide H. pylori antibiotic resistance: A systematic. J Gastrointestin Liver Dis 2010;19:409-14.
13. Sirous M, Mehrabadi JF, Daryani N, Eshraghi S, Hajikhani S, Shirazi M. Prevalence of antimicrobial resistance in Helicobacter pylori isolates from Iran. Afr J Biotechnol 2010;9:5962-5.
14. Falsafi T, Mobasheri F, Nariman F, Najafi M. Susceptibilities to different antibiotics of Helicobacter pylori strains isolated from patients at the pediatric medical center of Tehran, Iran. J Clin Microbiol 2004;42:387-9.
15. Xia HX, Fan XG, Talley NJ. Clarithromycin resistance in Helicobacter pylori and its clinical relevance. World J Gastroenterol 1999;5:263-6.
16. Hao Q, Li Y, Zhang ZJ, Liu Y, Gao H. New mutation points in 23S rRNA gene associated with Helicobacter pylori resistance to clarithromycin in northeast China. World J Gastroenterol 2004;10:1075-7.
17. Shokrzadeh L, Jafari F, Dabiri H, Baghaei K, Zojaji H, Alizadeh A, et al. Antibiotic susceptibility profile of Helicobacter pylori isolated from the dyspepsia patients in Tehran, Iran. Saudi J Gastroenterol 2011;17:261-4.
18. Siavoshi F, Pourkhajeh AH, Merat S, Asl-Soleimani H, Heydarian E, Khatibian M, et al. Susceptibility of various strains of Helicobacter pylori to selected agents. Arch Iran Med 2000;3:60-3.
19. Mohammadi M, Doroud D, Mohajerani N, Massarrat S. Helicobacter pylori antibiotic resistance in Iran. World J Gastroenterol 2005;11:6009-13.
20. Mirzaei N, Poursina F, Faghri J, Talebi M, Khataminezhad MR, Hasanzadeh A, et al. Prevalence of resistance to Helicobacter pylori strains to selected antibiotics in Isfahan, Iran. J J Microbiol 2013;6:e6342.
21. Naser D. Genetic diversity and drug resistance of Helicobacter pylori strains in Isfahan, Iran. Iran J Basic Med Sci 2008;11:174-82.
22. Kargar M, Baghernejad M, Doosti A Ghorbani S. Clarithromycin resistance and 23S rRNA mutations in Helicobacter pylori isolates in Iran. Afr J Microbiol Res 2011;5:853-6.
23. Ahmad N, Zakaria WR, Abdullah SA, Mohamed R. Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori. World J Gastroenterol 2009;15:3161-5.
24. Ling TK, Leung WK, Lee CC, Ng EK, Yung MY, Chung MY, et al. The antimicrobial susceptibility of Helicobacter pylori in Hong Kong (1997-2001). Helicobacter 2002;7:327-8.
25. Kim JJ, Reddy R, Lee M, Kim JG, El-Zaatari FA, Osato MS, et al. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates form Korea. J Antimicrob Chemother 2001;47:459-61.
26. Andrzejewska E, Szkaradkiewicz A, Karpinski T. Antimicrobial resistance of Helicobacter pylori clinical strains in the last 10 years. Pol J Microbiol 2009;58:301-5.
27. Gerrits MM, van Vliet AH, Kuipers EJ, Kusters JG. Helicobacter pylori and antimicrobial resistance: Molecular mechanisms and clinical implications. Lancet Infect Dis 2006;6:699-709.
28. Siavoshi F, Saniee P, Latifi-Navid S, Massarrat S, Sheykholeslami A. Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline-comparison of three 3-year studies. Arch Iran Med 2010;13:177-87.
29. Rafeey M, Ghotaslou R, Nikvash S, Hafez AA. Primary resistance in Helicobacter pylori isolated in children from Iran. J Infect Chemother 2007;13:291-5.
30. Megraud F. H pylori antibiotic resistance: Prevalence, importance, and advances in testing. Gut 2004;53:1374-84.
31. Mendonca S, Ecclissato C, Sartori MS, Godoy AP, Guerzoni RA, Degger M, et al. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter 2000;5:79-83.
32. Kohanteb J, Bazargani A, Saberi-Firoozi M, Mobasser A. Antimicrobial susceptibility testing of Helicobacter pylori to selected agents by agar dilution method in Shiraz-Iran. Indian J Med Microbiol 2007;25:374-7.
33. Farshad S, Alborzi A, Japoni A, Ranjbar R, Hosseini Asl K, Badiee P, et al. Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran. World J Gastroenterol 2010;16:5746-51.
34. Shimoyama T, Fukuda S, Mikami T, Fukushi M, Munakata A. Efficacy of metronidazole for the treatment of clarithromycinresistant Helicobacter pylori infection in a Japanese population. J Gastroenterol 2004;39:927-30.
35. Dzierzanowska-Fangrat K, Rozynek E, Celińska-Cedro D, Jarosz M, Pawłowska J, Szadkowski A, et al. Antimicrobial resistance of Helicobacter pylori in Poland: A multicentre study. Int J Antimicrob Agents 2005;26:230-4.